Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$13.39 - $33.84
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $1.91B |
EV | $1.70B |
Shares Outstanding | 85.67M |
Beta | 1.33 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $26.75 |
P/E 2025E | 13.92x |
P/Revenue 2025E | 1.58x |
Revenue | 32.60% |
EPS | 35.50% |
Operating Cash Flow | 90.20% |
Free Cash Flow | 93.70% |
Revenue | 9.30% |
EPS | 7.20% |
Operating Cash Flow | 6.10% |
Free Cash Flow | 6.10% |
Gross Margin 2025E | 21.65% |
Net Profit Margin 2025E | 4.24% |
ROE 2025E | 29.16% |
ROCE 2024 | 11.14% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Progyny, Inc.
PGNY
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Anevski, Peter
Employees
678
Website
www.progyny.comIPO Date
2019-10-25
Headquarters
1359 Broadway, New York, New York, 10018, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved